Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2011 Apr;32(4):E71-2.
doi: 10.3174/ajnr.A2472. Epub 2011 Mar 24.

Imaging of bilateral neck paragangliomas with 68Ga-DOTATATE positron-emission tomography/CT

R C Quah
Case Reports

Imaging of bilateral neck paragangliomas with 68Ga-DOTATATE positron-emission tomography/CT

R C Quah. AJNR Am J Neuroradiol. 2011 Apr.
No abstract available

PubMed Disclaimer

Figures

Fig 1.
Fig 1.
Axial T1-weighted contrast-enhanced MR images reveals avidly enhancing lobulated masses in the bilateral carotid spaces of the neck, containing serpiginous signal-intensity voids.
Fig 2.
Fig 2.
Coronal T1-weighted contrast-enhanced MR image (A) and coronal 68Ga-DOTATATE PET-CT image (B) reveal intense tracer uptake within the enhancing bilateral carotid space masses.
See this image and copyright information in PMC

References

    1. Srirajaskanthan R, Kayani I, Quigley AM, et al. . The role of 68Ga-DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on 111In-DTPA-octreotide scintigraphy. J Nucl Med 2010;51:875–82.Epub 2010 May 19 - PubMed
    1. Haug AR, Auernhammer CJ, Wängler B, et al. . 68Ga-DOTATATE PET/CT for the early prediction of response to somatostatin receptor-mediated radionuclide therapy in patients with well differentiated neuroendocrine tumors. J Nucl Med 2010;51:1349–56 - PubMed
    1. Kupferman ME, Hanna EY. Paragangliomas of the head and neck. Curr Oncol Rep 2008;10:156–61 - PubMed
    1. Bodei L, Pepe G, Paganelli G. Peptide receptor radionuclide therapy (PRRT) of neuroendocrine tumors with somatostatin analogues. Eur Rev Med Pharmacol Sci 2010;14:247–51 - PubMed

Substances